Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D addition to conventional anti-TB therapy
NCT00366470Phase 3Completed
- Start
- Nov 2009
- Primary completion
- May 2012
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pulmonary tuberculosis (TB) comparing Vitamin D with Placebo (2 arms). Primary endpoint: Time to sputum culture conversion at 8 weeks. Started Nov 2009; status: completed.
02
Drugs
vitamin d
03
Conditions
pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT00366470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00366470.